Pioneer Municipal High Income Fund, Inc.
Change company Symbol lookup
Select an option...
MHI Pioneer Municipal High Income Fund, Inc.
GLW Corning Inc
PAYS Paysign Inc
ALTR Altair Engineering Inc
CVX Chevron Corp
ASCB ASPAC II Acquisition Corp
STRS Stratus Properties Inc
ESMC Escalon Medical Corp
ATO Atmos Energy Corp
LVS Las Vegas Sands Corp
Go

Company profile

Pioneer Municipal High Income Fund Inc (the Fund) is a diversified, closed-end management investment company. The investment objective of the Fund is to seek a high level of current income exempt from regular federal income taxes. The Fund may, as a secondary objective, also seek capital appreciation to the extent that it is consistent with its primary investment objective. Under normal market conditions, the Fund may invest at least 80% of its assets in debt securities and other obligations issued by or on behalf of states, territories and possessions of the United States and the District of Columbia and their political subdivisions, agencies and instrumentalities, the interest on which is exempt from regular federal income tax. Amundi Asset Management US, Inc. serves as the Fund’s investment adviser.

Closing Price
$8.21
Day's Change
0.04 (0.49%)
Bid
--
Ask
--
B/A Size
--
Day's High
8.26
Day's Low
8.14
Volume
(Below Average)
Volume:
74,436

10-day average volume:
92,404
74,436

Zymeworks rejects 'unsolicited, opportunistic' buyout bid by UAE-based All Blue Falcons

9:53 am ET May 20, 2022 (MarketWatch)
Print

Shares of Zymeworks Inc. (ZYME) rallied 1.5% in morning trading Friday, after the biopharmaceutical company said it rejected the "unsolicited, opportunistic, non-binding" $10.50-per-share buyout bid by activist investor All Blue Falcons FZE. The company said it determined that the bid by the UAE-based investment holding company "significantly undervalues" the company and its prospects, and "lacks credibility" by offering no information regarding funding. The stock had soared 23.2% on April 29, three days after closing at a record low, after the company confirmed it had received the bid from All Blue Falcons for $10.50 in cash. The stock had rallied to a post-bid high of $7.15 on May 3, which was 31.9% below the bid price, before pulling back. The stock was recently trading 43.7% below the bid price. The stock has plunged 63.9% year to date, while the iShares Biotechnology ETF (IBB) has dropped 24.3% and the S&P 500 has lost 17.5%.

-Tomi Kilgore

	

(END) Dow Jones Newswires

May 20, 2022 09:53 ET (13:53 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.